An illustrative case of Muir-Torre syndrome: Contribution of immunohistochemical analysis in identifying indicator sebaceous lesions

Archives of Dermatology

Volumn 142, Issue 8, 2006, Pages 1039-1042

  Marazza, Gionata ^a   Masouyé, Isabelle ^a   Taylor, Sophia ^a   Prins, Christa ^a   Gaudin, Thomas ^a   Saurat, Jean Hilaire ^a   French, Lars E ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

INTERMEDIN; MISMATCH REPAIR PROTEIN PMS2;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; COLON CANCER; COLON POLYP; GENETIC ANALYSIS; HUMAN; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; MALE; MICROSATELLITE MARKER; MISMATCH REPAIR; MUIR TORRE SYNDROME; PRIORITY JOURNAL;

ADENOCARCINOMA, SEBACEOUS; BACK; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; NOSE; SEBACEOUS GLAND NEOPLASMS;

EID: 33747618448     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.142.8.1039     Document Type: Article

References (17)

1. Muir EG, Bell AJY, Barlow KA. Multiple primary carcinoma of the colon, duodenum and larynx associated with keratoacanthoma of the face. Br J Surg. 1967;54:191-195.
2. Torre D. Multiple sebaceous gland tumors. Arch Dermatol. 1968;98:549-551.
3. Machin P, Catasus L, Pons C, et al. Microsatellite instability and immunostaining for MSH-2 and MLH-1 in cutaneous and internal tumors from patients with the Muir-Torre syndrome. J Cutan Pathol. 2002;29:415-420.
4. Ponti G, Losi L, Di Gregorio C, et al. Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacanthomas. Cancer. 2005;103:1018-1024.
5. Ponti G, Ponz de Leon M, Losi L, et al. Different phenotypes in Muir-Torre syndrome: clinical and biomolecular characterization in two Italian families. Br J Dermatol. 2005;152:1335-1338.
6. Moura C, Pacegueiro MM, Sachse MF, et al. Report of a case of Muir-Torre syndrome. J Eur Acad Dermatol Venereol. 2002;16:638-640.
7. Curry ML, Eng W, Lund K, Paek D, Cockerell CJ. Muir-Torre syndrome: role of the dermatopathologist in diagnosis. Am J Dermatopathol. 2004;26:217-221.
8. Burgdorf WHC, Pitha J, Fahmy A. Muir-Torre syndrome: histologic spectrum of sebaceous proliferations. Am J Dermatopathol. 1986;8:202-208.
9. Steffen C, Ackerman AB. Muir-Torre syndrome. In: Steffen C, Ackerman AB, eds. Neoplasm With Sebaceous Differentiation. Philadelphia, Pa: Lea & Febiger; 1992:559-664.
10. Troy JL, Ackerman AB. Sebaceoma: a distinctive benign neoplasm of adnexal epithelium differentiating toward sebaceous cells. Am J Dermatopathol. 1984;6:7-13.
11. Rütten A, Burgdorf W, Hügel H. Cystic sebaceous tumors as marker lesion for the Muir-Torre syndrome: a histopathologic and molecular genetic study. Am J Dermatopathol. 1999;21:405-413.
12. de la Chapelle A. Genetic predisposition to colorectal cancer. Nat Rev Cancer. 2004;4:769-780.
13. Kruse R, Ruzicka T. DNA mismatch repair and the significance of a sebaceous skin tumor for visceral cancer prevention. Trends Mol Med. 2004;10:136-141.
14. Kruse R, Rütten A, Schweiger N, et al. Frequency of microsatellite instability in unselected sebaceous gland neoplasias and hyperplasias. J Invest Dermatol. 2003;120:858-864.
15. Fiorentino DF, Nguyen J, Egbert B, et al. Muir-Torre syndrome: confirmation of diagnosis by immunohistochemical analysis of cutaneous lesions. J Am Acad Dermatol. 2004;50:476-477.
16. Graefe T, Wollina U, Schulz H, Burgdorf W. Muir-Torre syndrome: treatment with isotretinoin and interferon alpha-2a can prevent tumor development. Dermatology. 2000;200:331-333.
17. Vajda A, Scharrer K, Balo-Banga JM. Multiple sebaceous tumors with colon cancer: Muir-Torre syndrome. Orv Hetil. 2003;144:985-989.